Opportunity Screener
Filter the public universe by valuation gap, quality, momentum, and signal strength. Move from market-wide noise to a prioritized watchlist in one pass.
Equity research, intelligent
Find the value the market missed.
A research workstation that scans public markets for mispriced equities, runs the comparables, and watches every catalyst — so your thesis stays current.
Built for
- Public-market research
- Factor-aware screening
- Catalyst tracking
- Risk-first analysis
Capabilities
From the broad market to a prioritized watchlist in minutes.
Screen by valuation, quality, sentiment, and catalyst signals — all in a single workspace built for analysts who do their own work.
AI research summary
Earnings, filings, news, and peer context — compressed into a clean thesis you can read in two minutes, with citations to every source.
Risk & thesis monitor
Drawdown, concentration, and thesis-drift alerts. We tell you when a position no longer matches the case you originally bought — before the headline does.
Catalyst & comparable analysis
Peer multiples, valuation bands, upcoming catalysts, and upside/downside scenarios — side by side, not buried in five tabs.
Methodology
How the screening works.
Five stages, every name. No black-box scores you can't audit.
1Data sources
2Normalization
3Scoring
4Thesis generation
5Watchlist & alerts
Scoring you can audit
Each candidate is scored on a multi-factor composite — valuation gap, quality, momentum, and signal strength. Weights adjust to the macro regime instead of relying on static defaults, and every component is explained in plain language so you can argue with it.
Monitoring that doesn't sleep
Once a name lands on your watchlist, we track every catalyst, filing, earnings revision, and peer move. If your thesis changes — multiple compression, sector rotation, guidance cut — you'll see it the moment the data does, not on the next quarterly review.
The workspace
One workspace. Every signal.
Built for analysts, PMs, and serious self-directed investors who want the data to keep up.
Screener· 28 names matched
Top signals
Catalyst window
Saved
| Ticker | Sector | Val gap | Quality | Catalyst | Risk | Confidence |
|---|---|---|---|---|---|---|
| ACMX | Health | +34% | A− | Q3 earnings · 14d | Low | 0.86 |
| NMTC | Industrials | +22% | B+ | Capacity guide · 28d | Med | 0.74 |
| ARGO | Financials | +19% | A | Buyback window | Low | 0.81 |
| KNDR | Consumer | +16% | B | Brand relaunch · 42d | Med | 0.68 |
| VLNT | Tech | −9% | B− | Margin reset risk | High | 0.42 |
Thesis · ACMX
ACMX is trading at 0.8× EV/Sales versus the sector median of 1.4×, with margins inflecting positive after a two-year reset. Q3 commentary signaled durable pricing power; insider buying picked up in the last 30 days. Primary risks: a single payer concentration above the sector and a leveraged balance sheet that limits downside flex. Catalyst window opens with Q3 earnings in 14 days.
Start finding the equities the market mispriced.
Early access for analysts, PMs, and serious self-directed investors. No credit card. No newsletter spam.